Enzymotec , a member of the Galam Group, will introduce, at the upcoming FIE in London, its innovative ingredients designed to address several health needs and conditions. One of these ingredients is the CardiaBeat™, innovative proprietary sterol-based matrix. Earlier this year the product gained Novel Food approval from the European heath authorities. CardiaBeat is applicable for food products as dairy products (yogurt, dairy drinks, etc), spreads and others.
Enzymotec will also exhibit an advanced line of Phosphatidylserine based ingredients for cognitive performance. Phosphatidylserine is a natural building block of brain cell membrane crucial for brain activities such as memory, learning, etc. This platform includes the company's high quality SharpPSTM (Phosphatidylserine), which is suitable for a wide range of food applications. One of the applications is "Memo Bite" – a fine bittersweet chocolate bite enriched with SharpPSTM that provides half of the recommended daily intake of this important nutrient.
In addition to SharpPSTM Enzymotec is offering the next generation of phosphatidylserine- based ingredients including SharpPSTM SILVER and SharpPSTM GOLD.
Enzymotec is a developer and manufacturer of innovative, lipid-based biofunctional ingredients for dietary supplements, functional foods, clinical nutrition and advanced infant nutrition
key product are:, SharpPS™ line of products, InFat™ - structured fat for infant formulas , Krill Oil+ ™ and CardiaBeat™
South Hall Booth no. G90
Ms. Michal Haim-Bravman
E-mail: [email protected]